Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOLLYWOOD: Inhaled Iloprost in COPD
NCT07263958Not yet recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
01
Overview
Open-label, single-arm trial of iloprost in pulmonary hypertension (PH), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Pulmonary Vascular Resistance at 12 weeks. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07263958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07263958.